Elizabeth Vincan

Prof. Elizabeth Vincan

1. Department of Infectious Diseases, Melbourne Medical School, University of Melbourne, Melbourne, VIC 3000, Australia
+1
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2008 in EMBO Reports
Verified
Journal Article
Open access
PDF file
UBUlrike Burk
Ulrike Burk
JSJörg Schubert
Jörg Schubert
Ulrich Friedrich WellnerUlrich Friedrich Wellner
Ulrich Friedrich Wellner
OSOtto Schmalhofer
Otto Schmalhofer
Elizabeth VincanElizabeth Vincan
Elizabeth Vincan
TBThomas Brabletz
Thomas Brabletz
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

19 March 2008 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
Elizabeth VincanElizabeth Vincan
Elizabeth Vincan
NBNick Barker
Nick Barker

1 May 2015 in Stem Cell Reports
Verified
Journal Article
Open access
DFDustin Flanagan
Dustin Flanagan
TPToby Phesse
Toby Phesse
NBNick Barker
Nick Barker
RSRenate H.M. Schwab
Renate H.M. Schwab
NANancy Amin
Nancy Amin
Elizabeth VincanElizabeth Vincan
Elizabeth Vincan
The mammalian adult small intestinal epithelium is a rapidly self-renewing tissue that is maintained by a pool of cycling stem cells intermingled with Paneth cells at the base of crypts. These crypt base stem cells exclusively express Lgr5 and require Wnt3 or, in its absence, Wnt2b. However, the Frizzled (Fzd) receptor that transmits these Wnt signals is unknown. We determined the expression profile of Fzd receptors in Lgr5(+) stem cells, their immediate daughter cells, and Paneth cells. Here we show Fzd7 is enriched in Lgr5(+) stem cells and binds Wnt3 and Wnt2b. Conditional deletion of the Fzd7 gene in adult intestinal epithelium leads to stem cell loss in vivo and organoid death in vitro. Crypts of conventional Fzd7 knockout mice show decreased basal Wnt signaling and impaired capacity to regenerate the epithelium following deleterious insult. These observations indicate that Fzd7 is required for robust Wnt-dependent processes in Lgr5(+) intestinal stem cells.

1 November 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SRSteven P. Rockman
Steven P. Rockman
SCScott A. Currie
Scott A. Currie
MCMarianne Ciavarella
Marianne Ciavarella
Elizabeth VincanElizabeth Vincan
Elizabeth Vincan
CDChris Dow
Chris Dow
WPWayne Phillips
Wayne Phillips
Activation of beta-catenin/T cell factor (TCF) transcription as a result of mutations in the adenomatous polyposis coli (APC) and/or beta-catenin genes occurs in the majority of colon tumors. An increasing number of genes, including c-myc and cyclin D1, have been implicated as targets of this pathway. We now report that the dominant negative helix-loop-helix regulator Id2 is also a target of the beta-catenin/TCF transcription pathway in colon adenocarcinoma. Investigation of the mechanism for the overexpression of Id2 in colon carcinoma cells demonstrated that the Id2 promoter is activated, and the Id2 protein is up-regulated by beta-catenin. Conversely, reducing free beta-catenin blocked this induction of promoter activity. We have also used an electrophoretic mobility shift assay and supershift to identify a motif in the Id2 promoter that binds to TCF4 protein. Site-directed mutagenesis of this motif abolished promoter reporter activity. Both transfection of Id2 into SW480 cells and induction of Id2 in HT29 colon cells was found to increase anchorage-independent survival of these cells. Growing evidence associates disruption to Id2 expression with tumorigenesis, and our findings suggest that this dysregulation of Id2 expression is due to the activation of the beta-catenin/TCF pathway.

23 March 2018 in Genes
Verified
Journal Article
Open access
PDF file
DFDustin Flanagan
Dustin Flanagan
CAChloe Austin
Chloe Austin
Elizabeth VincanElizabeth Vincan
Elizabeth Vincan
TPToby Phesse
Toby Phesse
Wnt signalling regulates several cellular functions including proliferation, differentiation, apoptosis and migration, and is critical for embryonic development. Stem cells are defined by their ability for self-renewal and the ability to be able to give rise to differentiated progeny. Consequently, they are essential for the homeostasis of many organs including the gastrointestinal tract. This review will describe the huge advances in our understanding of how stem cell functions in the gastrointestinal tract are regulated by Wnt signalling, including how deregulated Wnt signalling can hijack these functions to transform cells and lead to cancer.

15 May 2011 in Cancer Research
Verified
Journal Article
Open access
PDF file
ASAnuratha Sakthianandeswaren
Anuratha Sakthianandeswaren
MCMichael Christie
Michael Christie
CDCarla D'ANdreti
Carla D'ANdreti
CTCary Tsui
Cary Tsui
RJRobert N. Jorissen
Robert N. Jorissen
Oliver SieberOliver Sieber
Oliver Sieber
Studies employing mouse models have identified crypt base and position +4 cells as strong candidates for intestinal epithelial stem cells. Equivalent cell populations are thought to exist in the human intestine; however robust and specific protein markers are lacking. Here, we show that in the human small and large intestine, PHLDA1 is expressed in discrete crypt base and some position +4 cells. In small adenomas, PHLDA1 was expressed in a subset of undifferentiated and predominantly Ki-67–negative neoplastic cells, suggesting that a basic hierarchy of differentiation is retained in early tumorigenesis. In large adenomas, carcinomas, and metastases PHLDA1 expression became widespread, with increased expression and nuclear localization at invasive margins. siRNA-mediated suppression of PHLDA1 in colon cancer cells inhibited migration and anchorage-independent growth in vitro and tumor growth in vivo. The integrins ITGA2 and ITGA6 were downregulated in response to PHLDA1 suppression, and accordingly cell adhesion to laminin and collagen was significantly reduced. We conclude that PHLDA1 is a putative epithelial stem cell marker in the human small and large intestine and contributes to migration and proliferation in colon cancer cells. Cancer Res; 71(10); 3709–19. ©2011 AACR.